Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 38 for “"B-cell malignancy"”.
-
Plasma cell differentiation in the B-cell malignancy Waldenström Macroglobulinemia
… macroglobulinemia (WM) is unique amongst B-cell malignancies in that the neoplastic cells retain the capacity to undergo plasma cell differentiation. This gives rise to a clonal neoplasm encompassing the spectrum of differentiation and as such presents a challenge to model and treat …
-
Targeting of B-cell malignancy using novel parallel chimeric antigen receptor (pCAR) engineered T-cells
… failure and recurrence of disease after CAR T-cell therapy are considerable obstacles to overcome. Here, parallel (p)CARs in which a second-generation (CD28+CD3z) CAR is co-expressed with a 4-1BB containing chimeric co-stimulatory receptor (CCR), were engineered. The hypothesis underlying pCAR …
-
A study of CD4+ follicular helper T cells in the follicular lymphoma microenvironment and normal germinal centres
Follicular lymphoma is a common B cell malignancy which usually follows an indolent course but it is a heterogeneous disease and there are no biomarkers that can accurately predict outcome or prognosis at the time of diagnosis. There is now clear evidence that the microenvironment plays an …
-
ΜΕΛΕΤΗ ΤΗΣ ΑΓΓΕΙΙΤΙΔΑΣ ΣΤΑ ΚΑΚΟΗΘΗ ΛΕΜΦΩΜΑΤΑ ΚΑΙ ΤΗΝ ΧΡΟΝΙΑ ΛΕΜΦΟΓΕΝΗ ΛΕΥΧΑΙΜΙΑ
… PATIENTS (13/14) HAD ADVANCED (STAGEIII OR IV) B-CELL MALIGNANCY OF LOW OR INTERMEDIATE GRADE. ALSO 13/14 DEVELOPED VASCULITIS IN A MEDIAN TIME OF 32 MONTHS (RANGE 2-122) FOLLOWING THE DIAGNOSIS OF THE NHL OR CLL. VASCULITIS INVOLVED MAINLY THE SKIN AND WAS CHARACTERIZED BY A PALPABLE …
-
Epidemiological study of chronic lymphocytic leukemia (CLL) in the province of Manitoba, Canada
… Follicular Lymphoma (FL), a similar indolent B cell malignancy, was only observed after CLL diagnosis indicating that a CLL-specific factor may be responsible for the increased risk of second cancers in these patients. The risk of second cancers is independent of treatment and surveillance bias …
-
Molecular and cellular studies of zoledronic acid : a potent inhibitor of multiple myeloma-induced osteolysis
Myelomatosis (MM) is an incurable B cell malignancy, characterised by the presence of osteolytic bone lesions, a major cause of morbidity and mortality. This study investigated the effect of zoledronic acid, a potent nitrogen-containing bisphosphonate (BP), on myeloma cells and osteoblasts-like …
-
ZNF423 Defines a Targetable Transcriptional Dependency in NF1-Associated Malignant Peripheral Nerve Sheath Tumors
… specification and has been implicated in B cell malignancy where it maintains an undifferentiated cellular state. Here, we assessed the functional relevance of ZNF423 in MPNST. In a murine PNF tumor cell-of-origin model, Nf1 loss reduced Zfp423 (murine ortholog of ZNF423) expression, whereas …
-
Avaliação do perfil imunomolecular de pacientes diagnosticados com Leucemia Linfoide Aguda Philadelphia positiva
… characteristics of the immune profile of T or B cell malignancy, based on the expression profile of monoclonal antibodies (MoAb) directed against cell differentiation antigens by flow cytometry (FC). Several studies have found that blast cell immunophenotypes do not always have the …
-
Estudos do diagnóstico, classificação e avaliação prognóstica das Leucemias Linfoide Aguda no Rio Grande do Norte pela tecnologia de imunofenotipagem por citometria de fluxo
… characteristics of the immune profile of T or B cell malignancy, based on the expression profile of monoclonal antibodies (MoAb) directed against cell differentiation antigens by flow cytometry (FC). Several studies have found that blast cell immunophenotypes do not always have the …
-
Novel mechanisms involving B cell receptor (BCR) and B cell activating factor (BAFF) signaling pathways underlying human primary immunodeficiencies and malignancy
… and survival of human peripheral immature B cells relies on two critical signaling pathways: B cell receptor (BCR) signaling and the B cell activating factor (BAFF)/BAFF-receptor (BAFF-R) signaling axis. The quality of the BCR signal is regulated in a developmental manner. Self-reactive early …
-
A study of cytokine expression and function in myeloma clones
Multiple myeloma (MM) is a B cell malignancy characterised by the presence of a monoclonal population of terminally differentiated plasma cells in the bone marrow. It generally occurs in older people. Clinical manifestations result from monoclonal protein (immunoglobulin) production and …
-
In vitro selection and characterization of DNA aptamers against a multiple myeloma monoclonal protein
Multiple myeloma (MM) is a clonal B cell malignancy. The idiotype (Id) of the monoclonal (M) protein secreted by the tumor cells is a well–defined, tumor–specific marker. Thus, the Id has becomes an intriguing target for the treatment of MM. Aptamers binding to the Id with high affinity and …
-
Role of interleukin-6 signaling via the Jak/Stat pathway in human myeloma and effects on mediators of cell survival and proliferation
Multiple myeloma is a B-cell malignancy characterized by the latent accumulation in bone marrow of monoclonal plasma cells with a low proliferative index and an extended life span. Interleukin-6 (IL-6) is the major survival factor for myeloma tumor cells and induces signaling through the Signal …
-
The Role of NFATc1 in Burkitt Lymphoma and in Eµ-Myc induced B cell Lymphoma
Burkitt lymphoma (BL) is a highly aggressive B cell malignancy. Rituximab, a humanized antibody against CD20, in a combination with chemotherapy is a current treatment of choice for B-cell lymphomas including BL. However, certain group of BL patients are resistant to Rituximab therapy. Therefore, …
-
The Molecular regulation of apoptosis in b-cell neoplasms
… of life. Eliciting specific death of tumour cells and understanding the molecular mechanisms responsible provides a rational approach for developing these new therapies. One form of cell death induced in response to physiological or exogenous stress stimuli, oncogenic changes, or an absence …
-
Development and characterization of a novel model of ibrutinib resistance in Chronic Lymphocytic Leukemia (CLL) that displays sensitivity to PI3K inhibition
… Chronic Lymphocytic Leukemia (CLL) is a B-cell malignancy driven by a hyperactive B-cell receptor pathway (BCR-P). BCR signalling includes Bruton’s tyrosine kinase (BTK) activation of extracellular signal-regulated kinase 1 and 2 (ERK1/2)-mediated proliferation via phospholipase C gamma 2 …
-
Investigating Apoptosis Pathway In Chronic Lymphocytic Leukemia: Stromal Influence and Therapeutic Activation
Chronic lymphocytic leukemia (CLL) is a B-cell malignancy. High levels of Bcl-2 and IAP family proteins are responsible for apoptotic-resistance and accumulation of mature CLL lymphocytes in bone-marrow, lymph nodes and peripheral blood. Besides pro-survival proteins, supporting stromal cells as …
-
Modelling the ability of targeted drugs and immunotherapy to modulate anti-tumour T cell activity in Chronic Lymphocytic Leukaemia
… lymphocytic leukaemia (CLL) is a non-curative B cell malignancy characterised by profound T cell exhaustion and an understudied immunosuppressive tumour microenvironment (TME). Although current therapies such as targeted drugs (BTKis, BCL-2i) alone or in combination with monoclonal antibodies …
-
Development of DNA vaccines against B-cell neoplasms
<p>For the development of DNA vaccines for B-cell malignancies, three aspects were studied. First, tumour Ig genes of B-cell malignancies were analysed to gain insight into the nature of the tumour antigen and the cell of origin in B-cell tumours. Transcripts of V<sub>H</sub>DJ<sub>H</sub>-constant …
-
Modelling chronic lymphocytic leukaemia (CLL) cell: microenvironment interactions in two- and three-dimensional culture systems
Chronic lymphocytic leukaemia (CLL) is a common B-cell malignancy characterised by the Accumulation of malignant B cells in the blood, bone marrow and secondary lymphoid Organs. CLL cells rapidly undergo apoptosis when cultured in vitro, highlighting the Importance of supporting tissue …
Page 1 of 2